Table 3.

BMI, blood pressure and biochemical characteristics pre and post a 10-week physical activity and nutrition intervention compared to a control group.

VARIABLE	GROUP	N	PRE (M ± SD)	POST (M ± SD)
BMI (kg/m2)	PAN	22	30.8 ± 5.4	29.8 ± 5.7**
	Control	19	27.6 ± 5.3	27.7 ± 5.29
BMI z-score	PAN	22	2.46 ± 0.79	2.24 ± 0.89**
	Control	19	2.10 ± 0.82	2.03 ± 0.83
Systolic Blood Pressure (mmHg)	PAN	22	125.9 ± 15.7	115.2 ± 12.4*
	Control	19	117.3 ± 17.5	114.9 ± 13.9
Diastolic Blood Pressure (mmHg)	PAN	22	76.1 ± 8.1	73.3 ± 7.3
	Control	19	72.3 ± 7.8	70.0 ± 10.7
ALT (U/L)	PAN	22	18.1 ± 6.1	16.9 ± 5.6
	Control	17	18.9 ± 9.9	22.1 ± 22.4
Triglycerides (mmol/L)	PAN	19	0.74 ± 0.42	0.69 ± 0.29
	Control	15	0.64 ± 0.94	0.64 ± 0.11
HDL (mmol/L)	PAN	19	1.34 ± 0.29	1.32 ± 0.26
	Control	15	1.44 ± 0.42	1.44 ± 0.36
LDL (mmol/L)	PAN	19	2.63 ± 0.66	2.37 ± 0.49*
	Control	15	2.25 ± 0.69	2.36 ± 0.73
Glucose (mmol/L)	PAN	19	4.63 ± 0.42	4.63 ± 0.44
	Control	15	4.41 ± 0.43	4.45 ± 0.44
HbA1c (%)	PAN	22	5.4 ± 0.35	5.6 ± 0.44*
	Control	17	5.38 ± 0.27	5.57 ± 0.27^
Insulin (mU/ml)	PAN	21	13.95 ± 5.48	12.82 ± 4.10
	Control	15	10.39 ± 5.55	13.30 ± 5.21
HOMA-IR	PAN	19	3.01 ± 1.22	2.72 ± 0.95
	Control	15	2.06 ± 1.16	2.79 ± 1.01

M – Mean; SD – Standard deviation; ALT – Alanine aminotransferase; HDL-C – High-density lipoprotein cholesterol; LDL-C – Low-density lipoprotein cholesterol; HOMA-IR – Homeostatic model assessment of insulin resistance.

* p < 0.05, pre PAN vs post PAN; ** p < 0.01, pre PAN vs post PAN.

^ p < 0.01, pre CG vs post CG.